Non-life speciality insurer R&Q Insurance Holdings has received a capital infusion of $50m from Scopia Capital Management, which is one of its biggest shareholders.
There is also the provision to boost the amount of equity raised to $60m.
Go deeper with GlobalData
Scopia subscribed for preferred stock issued by Randall & Quilter PS Holdings, an indirect subsidiary of R&Q, for $50m.
At Scopia’s will, the preferred stock could be exchanged into new ordinary shares of R&Q at a 10% premium to the 20-day volume-weighted average price before the agreement.
The infusion will support the separation of the firm’s legacy insurance R&Q Legacy and programme management Accredited businesses.
These two businesses will currently run under the group’s two separate holding companies.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalDataThe capital injection would be used to boost R&Q Legacy’s capitalisation and for general corporate purposes, as Accredited would not pay intra-group dividends to receive its financial strength rating from AM Best.
The separation is a prerequisite to help Accredited secure AM Best’s own subgroup financial strength rating.
R&Q has obtained all essential clearances to finalise this internal overhaul.
The group is currently assessing strategic deals with third parties to help Accredited run independently.
It is also weighing a potential divestment of Accredited and said it has received expressions of interest from various parties.
Several strategic alternatives are also being evaluated for R&Q Legacy.
Announcing the Q1 2023 update for Accredited, R&Q said that the business saw a 34% surge in gross written premiums from the year-ago quarter to $0.5bn.
Programme fee income increased 24% to $22m from $18m over the period.
R&Q CEO William Spiegel said: “This additional capital, alongside our completed internal reorganisation, means Accredited and R&Q Legacy can be established as stand-alone entities within R&Q.
“2023 has seen Accredited continue its strong momentum and leadership position in the programme market, achieving a record first quarter in terms of GWP and Fee Income.”
